Science
Remdesivir is more effective for COVID-19 than standard treatment – The Times Hub
Investing.com – A study by biotech company Gilead Sciences Inc (NASDAQ: GILD) found that a short, 5-day course of treatment of moderately severe hospitalized patients
Investing.com – A study by biotech company Gilead Sciences Inc (NASDAQ: GILD) found that a short, 5-day course of treatment of moderately severe hospitalized patients with COVID-19 with experimental remdesivir was more effective than 10 days and than standard treatment, writes Market Watch.
The results of the third phase of the open-label studies were published in the American scientific journal of the medical association JAMA. The company has already received permission for emergency use of …
-
Noosa News24 hours agoMan dies after ride on mower rolls in Hampton, near Toowoomba
-
Noosa News23 hours agoComing Soon: Wilderluxe Lake Keepit Is the Luxe Countryside Escape That Combines Curated Adventure and Inspired Stargazing
-
Noosa News23 hours agoGout Gout breaks 10 seconds for 100m with illegal tailwind at Australian Athletics Championships
-
Noosa News22 hours agoState clears the way for farmland on Brisbane fringe to be developed